Category: Side Effect: Kidney Injury (chronic kidney disease, acute renal failure)
-
Reclast “Dear Doctor” Letter For Kidney Problems Should Be Sent By Novartis In U.S.
Public Citizen March 2011 Letter To FDA Points To Aclasta Safety Alert Material Sent In Canada During October 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: On September 1, 2011 the FDA announced…
-
Osteoporosis Medication Aclasta Associated With Renal Impairment And Kidney Failure
Novartis Sends "Dear Doctor" Letter To Canadian Physicians With Health Canada Endorsed Safety Information (Posted by Tom Lamb at DrugInjuryWatch.com) In 2007 Aclasta (zoledronic acid 5mg) was approved by the FDA under the brand name Aclasta®…
-
Is Bayer Warning Or Attacking With Its New YAZ / Yasmin Package Insert, Or Label, In The U.S.
Bayer Says YAZ / Yasmin Safety Profile Is Comparable To Older Birth Control Pills, But European Regulators See Possible Increased Risk Of Blood Clot Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: "Bayer…
-
FDA And Novartis Announce A Label Change For Iron Chelating Drug Exjade In Mid-February 2010
Includes A New "Black Box" Warning About Renal Impairment, Liver Failure, And Gastrointestinal Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 the FDA and Novartis announced a change to the Prescribing Information…
-
YAZ, Yasmin, Ocella: 1,100 Lawsuits Filed As Of Mid-February 2010, According To Bayer
Company Annual Report 2009: "Bayer believes that it has meritorious defenses and intends to defend itself vigorously." (Posted by Tom Lamb at DrugInjuryWatch.com) The Bayer Annual Report for 2009, at page 243, provides some updated…
-
FDA Wants Studies Done On Byetta Safety, With Focus On Pancreatitis, Pancreatic Cancer, Thyroid Neoplasm, And Acute Renal Failure
FDA Letter About Byetta Sent To Amilyn In October 2009; Drug Company Tries To Downplay, But Investors React When They Learn About It In December 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) On October…
-
Diabetes Drug Byetta Linked To Kidney Problems And Cases Of Renal Failure
October 2009 Byetta Label Change Follows Earlier Alert From U.K. About Kidney-Related Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2009 the Drug Safety Update Newsletter alerted us about reports of kidney-related…
-
October 2009: Yasmin And Yaz Multidistrict Litigation (MDL) Transfer Order For Injury And Death Cases Filed In Federal Court
MDL No. 2100 — IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation — Assigned To Southern District of Illinois (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Our Focus…
-
Yasmin / YAZ Multidistrict Litigation (MDL) Motion Filed Late July 2009
Requests Consolidation Of Federal Court Lawsuits Alleging Yasmin Or YAZ Caused Injury Such As Stroke, Heart Attack, Pulmonary Thrombosis, Deep Vein Thrombosis, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ Update: On October 1,…
-
Hydroxycut Weight-Loss Products Are Recalled Due To Cases Of Serious Liver Injury
Reports Made To The FDA Have Involved Hepatitis, Liver Failure, Liver Transplant, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) On May 1, 2009 the FDA warned people to stop using Hydroxycut products – made…